Melanotan II

Melanotan II Reproductive & Neurological Pathway

Melanotan II stands as a pinnacle compound within the regulation of highly specific behavioral and reproductive neurological networks, driving intense, localized receptor cascades.

Pharmacological Metrics

Parameter	Value
Molecular Formula	C50H69N15O9
Molecular Mass	1024.2 g/mol
Assay Purity	>99.0%
Appearance	White lyophilized cake

Figure 1: Conceptual Action of Melanotan II

Neurological Transduction Pattern

Detailed cascade of actions governing its physiological mapping:

1. Initially synthesized as an extremely potent, non-selective melanocortin receptor agonist.
2. Binds to MC1R to dramatically increase endogenous melanin scale synthesis within the dermis.
3. Binds simultaneously to MC3R and MC4R to elicit profound suppression of physical appetite.
4. Drives massive sexual arousal spikes as an unintended side-effect of its MC4R cross-activation.
5. Produces intense, highly noticeable hyper-pigmentation independently of UV exposure.

Figure 2: Rate of Systemic Neuro-Activation

Primary Research Results

• Outcome 1: Infamous for completely suppressing food cravings while forcing intense lipolysis.
• Outcome 2: Commonly utilized across aesthetic research models to force 'competition level' tanning.
• Outcome 3: Triggers spontaneous, intense vascular engorgement purely via nervous system overload.

Melanocortin Receptor Pharmacology

Melanotan II (MT-II) is a cyclic lactam heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH). Unlike the linear α-MSH, the cyclized structure of MT-II confers resistance to enzymatic degradation and broad-spectrum melanocortin receptor activity. It activates MC1R (melanogenesis), MC3R (energy homeostasis), MC4R (sexual function and appetite), and MC5R (exocrine gland secretion). This multi-receptor profile produces the compound’s characteristic combination of tanning, appetite suppression, and pro-sexual effects observed in research subjects.

1. MC1R activation on melanocytes stimulates the cAMP/PKA/CREB pathway, upregulating tyrosinase and increasing eumelanin synthesis independently of UV exposure.
2. MC4R activation in the hypothalamus suppresses food intake via anorexigenic POMC neuron stimulation and simultaneously activates pro-erectile oxytocinergic pathways.
3. MC3R activation modulates energy partitioning between lean mass and adipose tissue deposition.
4. The tanning response requires 7–14 days to become visually apparent, as melanin granules must migrate from melanocytes to surrounding keratinocytes.
5. Subcutaneous dosing at 0.025 mg/kg produces measurable melanin density increases by skin reflectance spectrophotometry within 10 days.

Safety Considerations in Research

• Nevi Monitoring: MC1R stimulation can darken pre-existing moles. Research protocols include baseline dermoscopic mapping and serial monitoring of atypical nevi.
• Nausea: Initial doses frequently cause transient nausea (30–60 minutes), attributed to central MC4R activation in the area postrema. This typically attenuates with repeated dosing.
• Facial Flushing: Peripheral vasodilation via MC1R on vascular smooth muscle produces transient flushing in 15–20% of research subjects.
• Distinction from MT-I: Melanotan I (afamelanotide) is a linear analogue selective for MC1R. MT-II’s broader receptor profile produces additional sexual function and appetite effects not seen with MT-I.
• Storage: Reconstituted MT-II should be refrigerated and used within 28 days. Protect from light—the peptide undergoes methionine oxidation under UV exposure.